nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—CYSLTR2—cardiovascular system—attention deficit hyperactivity disorder	0.0503	0.166	CbGeAlD
Nedocromil—FPR1—nervous system—attention deficit hyperactivity disorder	0.0291	0.096	CbGeAlD
Nedocromil—FPR1—central nervous system—attention deficit hyperactivity disorder	0.028	0.0924	CbGeAlD
Nedocromil—PTGDR—nervous system—attention deficit hyperactivity disorder	0.0275	0.0907	CbGeAlD
Nedocromil—PTGDR—central nervous system—attention deficit hyperactivity disorder	0.0264	0.0873	CbGeAlD
Nedocromil—PTGDR—brain—attention deficit hyperactivity disorder	0.021	0.0693	CbGeAlD
Nedocromil—HSP90AA1—forebrain—attention deficit hyperactivity disorder	0.0194	0.0642	CbGeAlD
Nedocromil—HSP90AA1—cardiovascular system—attention deficit hyperactivity disorder	0.0164	0.0543	CbGeAlD
Nedocromil—HSP90AA1—midbrain—attention deficit hyperactivity disorder	0.0128	0.0424	CbGeAlD
Nedocromil—CYSLTR1—nervous system—attention deficit hyperactivity disorder	0.0122	0.0401	CbGeAlD
Nedocromil—CYSLTR1—central nervous system—attention deficit hyperactivity disorder	0.0117	0.0387	CbGeAlD
Nedocromil—HSP90AA1—nervous system—attention deficit hyperactivity disorder	0.0105	0.0348	CbGeAlD
Nedocromil—HSP90AA1—central nervous system—attention deficit hyperactivity disorder	0.0102	0.0335	CbGeAlD
Nedocromil—HSP90AA1—cerebellum—attention deficit hyperactivity disorder	0.00992	0.0328	CbGeAlD
Nedocromil—CYSLTR1—brain—attention deficit hyperactivity disorder	0.00929	0.0307	CbGeAlD
Nedocromil—HSP90AA1—brain—attention deficit hyperactivity disorder	0.00806	0.0266	CbGeAlD
Nedocromil—CYSLTR1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.0026	0.00372	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00259	0.00372	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00254	0.00364	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00254	0.00364	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00253	0.00363	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00252	0.00362	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00249	0.00358	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00249	0.00358	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00248	0.00356	CbGpPWpGaD
Nedocromil—FPR1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00246	0.00353	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00246	0.00353	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00245	0.00351	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00245	0.00351	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00244	0.0035	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00244	0.0035	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00244	0.00349	CbGpPWpGaD
Nedocromil—CYSLTR2—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00241	0.00346	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00241	0.00345	CbGpPWpGaD
Nedocromil—HSP90AA1—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00239	0.00342	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00239	0.00342	CbGpPWpGaD
Nedocromil—PTGDR—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00238	0.00341	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00238	0.00341	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00235	0.00337	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.0023	0.00331	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00229	0.00329	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00228	0.00327	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular response to heat stress—EP300—attention deficit hyperactivity disorder	0.00228	0.00327	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00227	0.00325	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00224	0.00321	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00222	0.00319	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00222	0.00318	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00216	0.0031	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00215	0.00308	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00214	0.00306	CbGpPWpGaD
Nedocromil—HSP90AA1—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00213	0.00305	CbGpPWpGaD
Nedocromil—FPR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00211	0.00303	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00211	0.00302	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.0021	0.00301	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00207	0.00297	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00204	0.00293	CbGpPWpGaD
Nedocromil—PTGDR—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00204	0.00292	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00203	0.00292	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00201	0.00288	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00199	0.00286	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00199	0.00285	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00198	0.00284	CbGpPWpGaD
Nedocromil—HSP90AA1—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.00195	0.0028	CbGpPWpGaD
Nedocromil—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.00195	0.0028	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00194	0.00279	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00192	0.00276	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00191	0.00274	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00189	0.00271	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00187	0.00268	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00187	0.00268	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00185	0.00265	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00185	0.00265	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00182	0.00261	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00181	0.00259	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00181	0.00259	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00176	0.00252	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00175	0.00251	CbGpPWpGaD
Nedocromil—HSP90AA1—Regulation of Androgen receptor activity—EP300—attention deficit hyperactivity disorder	0.00175	0.0025	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00174	0.00249	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—MB21D1—attention deficit hyperactivity disorder	0.00173	0.00248	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00172	0.00247	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.0017	0.00244	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00169	0.00243	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00167	0.0024	CbGpPWpGaD
Nedocromil—CYSLTR1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00167	0.0024	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—SYNE1—attention deficit hyperactivity disorder	0.00166	0.00238	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00165	0.00237	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00163	0.00233	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00162	0.00232	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00161	0.0023	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.0016	0.00229	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.0016	0.00229	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.0016	0.00229	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00159	0.00228	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00158	0.00227	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00158	0.00226	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00155	0.00223	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00154	0.00221	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.0015	0.00215	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00148	0.00212	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00148	0.00212	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00145	0.00207	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00144	0.00207	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00144	0.00206	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00143	0.00206	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00143	0.00205	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00141	0.00202	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00141	0.00202	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00141	0.00202	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.0014	0.002	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00139	0.002	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00139	0.00199	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00138	0.00199	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00138	0.00198	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00138	0.00198	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00138	0.00198	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00138	0.00197	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00136	0.00195	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00136	0.00195	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00134	0.00193	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00134	0.00193	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00134	0.00191	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00133	0.00191	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00131	0.00188	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.0013	0.00187	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.0013	0.00186	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.0013	0.00186	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00129	0.00186	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00129	0.00186	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00128	0.00184	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00128	0.00184	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	0.00127	0.00182	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00127	0.00182	CbGpPWpGaD
Nedocromil—HSP90AA1—Validated targets of C-MYC transcriptional activation—EP300—attention deficit hyperactivity disorder	0.00127	0.00182	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00126	0.00181	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00126	0.0018	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00125	0.0018	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00125	0.0018	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00125	0.0018	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00124	0.00177	CbGpPWpGaD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—EP300—attention deficit hyperactivity disorder	0.00123	0.00177	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00122	0.00175	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00122	0.00175	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00121	0.00173	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00121	0.00173	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00118	0.00169	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00114	0.00163	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00113	0.00162	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00113	0.00162	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00112	0.00161	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00111	0.00159	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.0011	0.00157	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00109	0.00156	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00109	0.00156	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00107	0.00153	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00107	0.00153	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00105	0.00151	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00105	0.0015	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00103	0.00148	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00102	0.00146	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—MB21D1—attention deficit hyperactivity disorder	0.00101	0.00145	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000987	0.00141	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000983	0.00141	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000977	0.0014	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—STUB1—attention deficit hyperactivity disorder	0.000977	0.0014	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00097	0.00139	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000958	0.00137	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000957	0.00137	CbGpPWpGaD
Nedocromil—HSP90AA1—G2/M Transition—EP300—attention deficit hyperactivity disorder	0.000952	0.00137	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000944	0.00135	CbGpPWpGaD
Nedocromil—HSP90AA1—Mitotic G2-G2/M phases—EP300—attention deficit hyperactivity disorder	0.000939	0.00135	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000908	0.0013	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—STUB1—attention deficit hyperactivity disorder	0.000902	0.00129	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000892	0.00128	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00088	0.00126	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000877	0.00126	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000869	0.00125	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000854	0.00122	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000844	0.00121	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000836	0.0012	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000825	0.00118	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000825	0.00118	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000809	0.00116	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000796	0.00114	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000794	0.00114	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000778	0.00112	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000769	0.0011	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000767	0.0011	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00076	0.00109	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000756	0.00108	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000756	0.00108	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000753	0.00108	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000747	0.00107	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000743	0.00107	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000741	0.00106	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000741	0.00106	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—POLR3A—attention deficit hyperactivity disorder	0.00074	0.00106	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00074	0.00106	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000731	0.00105	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00073	0.00105	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000726	0.00104	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000721	0.00103	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000706	0.00101	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000695	0.000997	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000688	0.000987	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000684	0.000981	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000681	0.000977	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000672	0.000964	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000672	0.000963	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000664	0.000952	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000649	0.000931	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000647	0.000928	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000632	0.000906	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000625	0.000896	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000618	0.000887	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000602	0.000863	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000583	0.000836	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000573	0.000822	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000566	0.000811	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000543	0.000778	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000532	0.000762	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000527	0.000756	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000521	0.000748	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000513	0.000736	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000487	0.000699	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—EP300—attention deficit hyperactivity disorder	0.000483	0.000693	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000477	0.000684	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00047	0.000675	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000449	0.000643	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000448	0.000642	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000448	0.000642	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000441	0.000632	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000433	0.000621	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—SNAP25—attention deficit hyperactivity disorder	0.000428	0.000613	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000417	0.000598	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00041	0.000588	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000404	0.000579	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000397	0.000569	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000392	0.000562	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000369	0.000529	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000368	0.000528	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000365	0.000524	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000358	0.000514	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000341	0.000489	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000322	0.000462	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.000303	0.000434	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000299	0.000429	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000293	0.00042	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00029	0.000416	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000285	0.000409	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000281	0.000404	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000271	0.000389	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.000271	0.000388	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000269	0.000386	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000262	0.000376	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000258	0.000371	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000258	0.00037	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000256	0.000367	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000249	0.000357	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000196	0.00028	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000184	0.000263	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—EP300—attention deficit hyperactivity disorder	0.000151	0.000216	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—EP300—attention deficit hyperactivity disorder	0.000139	0.000199	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000136	0.000194	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000116	0.000167	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	9.73e-05	0.00014	CbGpPWpGaD
